Taasti Vicki Trier, Hattu Djoya, Peeters Stephanie, van der Salm Anke, van Loon Judith, de Ruysscher Dirk, Nilsson Rasmus, Andersson Sebastian, Engwall Erik, Unipan Mirko, Canters Richard
Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.
RaySearch Laboratories AB, Stockholm, Sweden.
Phys Imaging Radiat Oncol. 2023 Jun 17;27:100459. doi: 10.1016/j.phro.2023.100459. eCollection 2023 Jul.
Efficient workflows for adaptive proton therapy are of high importance. This study evaluated the possibility to replace repeat-CTs (reCTs) with synthetic CTs (sCTs), created based on cone-beam CTs (CBCTs), for flagging the need of plan adaptations in intensity-modulated proton therapy (IMPT) treatment of lung cancer patients.
Forty-two IMPT patients were retrospectively included. For each patient, one CBCT and a same-day reCT were included. Two commercial sCT methods were applied; one based on CBCT number correction (Cor-sCT), and one based on deformable image registration (DIR-sCT). The clinical reCT workflow (deformable contour propagation and robust dose re-computation) was performed on the reCT as well as the two sCTs. The deformed target contours on the reCT/sCTs were checked by radiation oncologists and edited if needed. A dose-volume-histogram triggered plan adaptation method was compared between the reCT and the sCTs; patients needing a plan adaptation on the reCT but not on the sCT were denoted false negatives. As secondary evaluation, dose-volume-histogram comparison and gamma analysis (2%/2mm) were performed between the reCT and sCTs.
There were five false negatives, two for Cor-sCT and three for DIR-sCT. However, three of these were only minor, and one was caused by tumour position differences between the reCT and CBCT and not by sCT quality issues. An average gamma pass rate of 93% was obtained for both sCT methods.
Both sCT methods were judged to be of clinical quality and valuable for reducing the amount of reCT acquisitions.
高效的自适应质子治疗工作流程至关重要。本研究评估了在肺癌患者的调强质子治疗(IMPT)中,用基于锥形束CT(CBCT)生成的合成CT(sCT)替代重复CT(reCT)以标记计划调整需求的可能性。
回顾性纳入42例IMPT患者。对于每位患者,纳入一次CBCT和同一天的reCT。应用了两种商业sCT方法;一种基于CBCT数学校正(Cor-sCT),另一种基于可变形图像配准(DIR-sCT)。在reCT以及两种sCT上执行临床reCT工作流程(可变形轮廓传播和稳健剂量重新计算)。放疗肿瘤学家检查reCT/sCT上变形的靶区轮廓,并在需要时进行编辑。比较了reCT和sCT之间剂量体积直方图触发的计划调整方法;在reCT上需要计划调整但在sCT上不需要的患者被视为假阴性。作为次要评估,在reCT和sCT之间进行了剂量体积直方图比较和伽马分析(2%/2mm)。
有5例假阴性,Cor-sCT有2例,DIR-sCT有3例。然而,其中3例只是轻微的,1例是由reCT和CBCT之间的肿瘤位置差异而非sCT质量问题导致的。两种sCT方法的平均伽马通过率均为93%。
两种sCT方法均被判定具有临床质量,对于减少reCT采集量具有价值。